Articles tagged with Pseudomonas
Researchers at the University of Notre Dame have discovered a key process for how gram-negative bacteria attach their outer membrane to the cell wall. The study found that protein PA2854 performs a chemical reaction linking the outer membrane to the cell wall, a crucial step in maintaining the bacterium's health.
Researchers from New England Biolabs and Yale University have developed a first fully synthetic bacteriophage engineering system using the High-Complexity Golden Gate Assembly platform. This method simplifies strain engineering techniques, allowing for rapid creation of tailored therapeutic strains to overcome antibiotic resistance.
Pseudomonas aeruginosa uses the type VI secretion system (T6SS) to counterattack when attacked by other bacteria, but this defense mechanism also makes it more vulnerable to antibiotics.
Researchers at HIPS and Helmholtz Centre for Infection Research discovered that tolcapone interacts with LecA protein, a key component of Pseudomonas aeruginosa. The study identified several derivatives that inhibit LecA significantly more strongly than tolcapone.
Researchers found that hospital-acquired bacteria Pseudomonas aeruginosa often spread from the lungs to the gut in patients, heightening the risk of life-threatening sepsis. The study also identified frequent DNA changes associated with antimicrobial resistance, making treatment more difficult.
Researchers at the University of Oregon have discovered a new treatment approach using a two-drug combination that is 10,000 times more effective than single-drug antibiotics in killing bacterial cells in lab tests. This promising method could help shorten treatment time and reduce toxicity in patients with chronic wound infections.
Researchers have discovered that Pseudomonas aeruginosa can functionally organize itself into diverse populations using epigenetic memory. This diversification allows the pathogen to adapt to changing conditions in the human body and evade the immune system, making infections difficult to treat.
The study identified two new families of natural compounds, syrilipamides and secimides, produced by the bacterium. These molecules show remarkable toxicity against competing microorganisms, particularly fungi and amoebae. The discovery also highlights the importance of the SecA enzyme in expanding the chemical repertoire of Pseudomona...
A new study presents a two-step method to effectively dismantle bacterial biofilms and prevent regrowth. By using self-locomotive antibacterial microbubblers (SLAM) followed by a mixture of hydrogen peroxide and peroxyacetic acid, researchers were able to prevent the regrowth of biofilms on surfaces, including medical instruments.
The international conference will focus on translating phage research into clinical reality, exploring key sessions and major speakers. Companies from various sectors are attending the event, highlighting the growing interest in phage therapy.
A study found that co-infection by Pseudomonas aeruginosa and Mycobacterium abscessus suppresses immune responses, leading to worsened lung function decline in patients with cystic fibrosis and COPD. The presence of both bacteria together reduces the production of key immune signalling molecules, effectively dampening the body's inflam...
A groundbreaking study has identified a dual-target approach that significantly prevents the development of resistance in bacteria. This approach combines membrane disruption with an additional critical cellular pathway, offering a potential solution to mitigate the escalating threat of antimicrobial resistance.
A study found that even with impeccable cleaning, hospital sink drains can host bacterial populations that change over time. Dominant species include Stenotrophomonas and Pseudomonas aeruginosa, known to cause ventilator-associated pneumonia and sepsis.
Recent studies have found that new antibiotics are prone to rapid development of resistance, even before they are widely used. This raises concerns about the effectiveness of these treatments in the long run. To address this issue, researchers call for a shift in antibiotic development prioritizing novel modes of action and responsible...
A new study finds that disease-causing bacteria can infect a wide range of plant species, including non-flowering plants, using a common set of pathogenicity factors. The research suggests that the toxin syringomycin interferes with cell membranes across diverse plant species.
Researchers found that human histones have antimicrobial activity against bacteria, including Pseudomonas aeruginosa biofilms, reducing bacterial mass by up to 70% and survival time in infected larvae by 50%. The study suggests using histones or parts of these proteins as a promising alternative to combat acute and chronic infections.
The study found that P. aeruginosa adapts to the lung's mucus by relying on sugars and lactate, but also needs to synthesize essential nutrients through metabolic independence. Biofilm formation imposes a metabolic burden, slowing down the bacteria's ability to spread, while disrupting biofilms makes them more vulnerable to antibiotics.
The study describes the full molecular structure of the phage DEV, which infects and lysates Pseudomonas aeruginosa bacteria. The researchers discovered a genome ejection motor that pulls the DNA out of its head after infection, with conserved design principles across all Schitoviridae phages.
A new study reveals how three species of bacteria coexist in biofilms by playing a game of 'nice' and then moving out when the surface becomes too crowded. The dominant species, Pseudomonas aeruginosa, disperses to allow other species to thrive.
Researchers tested seven antibiotics in combination with various natural compounds, finding synergistic effects against multidrug-resistant bacteria. The study suggests combining antibiotics with plant extracts or phytochemicals could be a promising strategy to combat antimicrobial resistance.
Scientists used advanced computing tools to engineer Pseudomonas putida for isoprenol production, achieving the highest reported yield. The research paves the way for a sustainable bioproduction process for jet fuel by optimizing isoprenol production in P. putida.
A new study using Raman spectroscopy has identified Pseudomonas bacteria from turtle skin in just 5-30 minutes, offering a faster alternative to traditional methods. The technique provides detailed information about bacterial chemical structure and holds great potential for future research on other microorganisms.
Letters in Applied Microbiology invites submissions on Pseudomonas biotechnology, covering applied biotechnology and metabolic engineering, as well as novel genetic tools. Early-career researchers are encouraged to share their work, fostering collaboration and inspiring future innovations.
A team of researchers has found a way to get antibacterial drugs through the outer membrane of Pseudomonas aeruginosa, making it more vulnerable to treatment. By using machine learning and testing various compounds, they discovered how to create new compounds that can penetrate the bacterium's defenses.
A study by Florida Atlantic University found that nearly all wristbands (95%) are contaminated with harmful bacteria, including E. coli and staphylococcus. The study suggests using metal types like gold and silver, which had little to no bacteria, and recommends regular sanitizing of wristbands, especially after gym activities.
Researchers used phage PASA16 to treat tough Pseudomonas aeruginosa infections, achieving an impressive 86.6% success rate. The study demonstrated the potential effectiveness of phage therapy as a valuable alternative to conventional antibiotics in combating antibiotic-resistant pathogens.
Researchers developed AirGels, bioengineered models of human lung tissue, to study airway infections in a more realistic manner. They found that Pseudomonas aeruginosa induces contraction of the host's mucus using type IV pili, contributing to biofilm formation.
Researchers found that antimicrobial resistance emerges from selection for pre-existing resistant clones, not new mutations. Infections with multiple pathogen clones show increased resistance to antibiotics, but also potential for faster loss of resistance when no antibiotics are present.
Researchers at Georgia Institute of Technology have discovered a gene that drives the switch between chronic and acute P. aeruginosa infections. The gene encodes a small RNA called SicX, which plays a vital role in bacterial respiration under low oxygen conditions.
Researchers at Leibniz-HKI discovered keanumycins in bacteria of the genus Pseudomonas, effective against plant fungal diseases like grey mould rot and human-pathogenic fungi like Candida albicans. The natural product could be an environmentally friendly alternative to chemical pesticides.
A potent plant toxin called albicidin has emerged as a strong new antibiotic candidate, effective in small concentrations and highly potent against pathogenic bacteria. Its unique mechanism targets the bacterial enzyme DNA gyrase, which is essential for cell function.
Researchers have designed a treatment that uses a modified bacterium to target and dissolve biofilms caused by Pseudomonas aeruginosa, a leading cause of hospital mortality. The treatment has shown significant efficacy in mice, reducing lung infections and doubling survival rates.
A study by researchers from the University of Tsukuba found that treating cabbage leaves with multiple amino acids can prevent disease caused by Pseudomonas cannabina pv. alisalensis, a bacterium that causes blight in brassica crops. The amino acids trigger stomatal closure, reducing bacterial entry and disease symptoms.
Researchers discovered antibiotic-resistant bacteria can travel from the gut to the lungs in a patient, highlighting the importance of preventing pathogenic bacteria from translocating to vital organs. The study's findings suggest eliminating resistant bacteria from the gut microbiome could help prevent serious infections.
Scientists from the University of Johannesburg identified ten times more volatile signal compounds from the bacteria, boosting plant growth and protection. Rhizobacteria can protect crops from abiotic and biotic stresses by producing valuable VOCs that trigger Induced Systemic Resistance (ISR) in plants.
Researchers found that smart windows with dynamic tinting can completely disinfect surfaces within 24 hours, reducing bacterial growth rates and viability. In contrast, traditional windows with blinds blocked almost all daylight, promoting contamination on glass, plastic, and fabric surfaces.
A study by Anglia Ruskin University has identified potentially dangerous Pseudomonas bacteria in 21% of wild bird faeces collected from locations near the River Cam. The bacteria, which can be passed on to humans through cross-contamination, were resistant to multiple antibiotics.
Researchers investigate Pseudomonas cannabina pv. alisalensis (Pcal) interaction with cabbage and oats, discovering coronatine (COR) suppresses salicylic acid to aid pathogen growth. This finding opens doors to new disease control strategies.
Dr. Jitender Mehla has received a National Institutes of Health Grant to study small molecule-based inhibition of multidrug efflux pump in Pseudomonas aeruginosa, a serious threat to hospital-acquired infections. The proposed research aims to develop antibacterials effective against multidrug-resistant Gram-negative pathogens.
Researchers found that Pseudomonas bacteria use a network of proteins to regulate twitching and respond to mechanical forces, allowing them to navigate based on what they feel in front of them. This 'sense of touch' helps the microbes move forward in the same direction when moving as a group.
Polyimidazolium compounds exhibited effective antimicrobial activity against Gram-negative bacteria, including Pseudomonas aeruginosa. The inability of this pathogen to evolve resistance suggests potential as a new class of antibiotics for combating antibiotic-resistant bacteria.
A major national study found that oral antibiotics are as effective as intravenous antibiotics in killing Pseudomonas aeruginosa, a common germ causing chronic lung infection in CF patients. This means CF patients with a new infection can be treated at home and saved from hospital admissions.
Researchers discover that Pseudomonas and Burkholderia use Type VI Secretion Systems to compete for dominance in the lungs of people with cystic fibrosis. As Pseudomonas adapts, it loses its competitive edge, allowing Burkholderia to establish infection.
Researchers discovered a potential new treatment for preventing sepsis in burn patients by using the secretions of probiotic bacteria Lactobacillus gasseri to combat antibiotic-resistant Pseudomonas aeruginosa. The study found that applying these secretions to the wound inhibited bacterial growth and prevented biofilm development.
The study identifies nine master regulators controlling key pathogenic pathways in Pseudomonas aeruginosa, offering potential targets for new antibiotics. An online platform and R package have also been developed to facilitate the analysis of the regulatory network.
Researchers from the University of Malaga have found that combining 'Bacillus subtilis' and 'Pseudomonas' bacteria can improve plant growth and health. This study reveals that these bacteria can live in harmony, increasing their positive effects when used together.
Researchers at Princeton University have engineered Pseudomonas bacteria to sense the speed of flowing fluids, which can be used as a flow sensor. The bacteria's genetic response is tuned to the speed, allowing it to detect and measure fluid flow in real-time.
Research found that gram-negative bacteria, excluding Pseudomonas, increase mortality, ICU admission, and vasopressor use in hospitalized patients with interstitial lung diseases (ILD). Patients infected with these organisms had higher 30-day mortality rates compared to those infected with other pathogens.
Researchers discovered that Pseudomonas aeruginosa rapidly overexpresses genes coding for proteins capturing host's iron and uses lactate, lipids, and collagen as nutrients. This knowledge opens the way to develop innovative treatments to counter its strategies.
A new study from McGill University Health Centre finds that newborn screening for cystic fibrosis results in better nutrition, fewer hospitalizations, and lower rates of infection. Children diagnosed through newborn screening are also diagnosed at an earlier age and benefit more from new treatments.
A new electrochemical detection strategy can identify bacteria in wounds in under a minute, allowing for targeted therapies and reduced healthcare costs. The method uses pyocyanin, a molecule produced by Pseudomonas bacteria, to detect infections.
Researchers at the University of Delaware have discovered a naturally occurring microbe that inhibits the devastating fungus known as rice blast, inducing a defense response in rice plants. The beneficial soil microbe, Pseudomonas chlororaphis EA105, reduces fungal growth by 76% and lesion size.
A study published in PLOS Pathogens demonstrates that an antimicrobial peptide produced by human immune cells can promote mutations in bacteria that make them more lethal. Researchers found that a specific immune system cell called polymorphonucleocytes can trigger bacterial conversion to a more resistant form.
Scientists create tiny houses for bacteria using a novel 3D printing technology, enabling precise control over bacterial interactions and growth. The method reveals that certain bacterial communities become more resistant to antibiotics when contained together, providing new insights into infection mechanisms.
Researchers at Brigham and Women's Hospital have discovered a new vaccine candidate for Pseudomonas aeruginosa, a bacterium that causes severe lung infections in patients with cystic fibrosis. The vaccine is based on a new mechanism of immunity mediated by T helper 17 (Th17) cells and has been shown to protect mice from lethal pneumonia.
Biochemist Alejandro Heuck maps molecular structure of needle-like tool used by bacteria to drill holes in mammalian cell walls. Researchers aim to identify new targets for developing drugs and treatments against diseases caused by bubonic plague, dysentery, food poisoning, and sepsis.
Researchers identified how Pseudomonas syringae uses coronatine to hijack a plant's defense system, keeping stomata open for bacterial invasion. The study provides insight into the full process of bacterial pathogenesis in plants.
Cystic fibrosis patients are vulnerable to Pseudomonas infection, which can be deadly. Researchers at Queen's University are working on a vaccine to combat this threat.
Research on space-bound bacteria like Pseudomonas aeruginosa could lead to improved treatments for people with compromised immune systems. The study reveals that spaceflight affects common regulators in both disease-causing bacteria.
Researchers have discovered a novel molecular mechanism that triggers plant infection by Pseudomonas syringae, a bacterium responsible for bacterial speck in tomatoes. The two-gene system is an evolutionary innovation that has provided the bacteria with a selective advantage, allowing them to infect a wide range of plants.